Cargando…
Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors
Allosteric HIV-1 integrase (IN) inhibitors, or ALLINIs, are a new class of antiviral agents that bind at the dimer interface of the IN, away from the enzymatic catalytic site and block viral replication by triggering an aberrant multimerization of the viral enzyme. To further our understanding of th...
Autores principales: | Dinh, Long Phi, Sun, Jian, Glenn, Courtney D., Patel, Krunal, Pigza, Julie A., Donahue, Matthew G., Yet, Larry, Kessl, Jacques J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324412/ https://www.ncbi.nlm.nih.gov/pubmed/35891446 http://dx.doi.org/10.3390/v14071466 |
Ejemplares similares
-
Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer
por: Sun, Jian, et al.
Publicado: (2021) -
Quinolines from the cyclocondensation of isatoic anhydride with ethyl acetoacetate: preparation of ethyl 4-hydroxy-2-methylquinoline-3-carboxylate and derivatives
por: Jentsch, Nicholas G, et al.
Publicado: (2018) -
HIV-1 Integrase-DNA Recognition Mechanisms
por: Kessl, Jacques J., et al.
Publicado: (2009) -
HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
por: Koneru, Pratibha C, et al.
Publicado: (2019) -
The mechanism of H171T resistance reveals the importance of N(δ)-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase
por: Slaughter, Alison, et al.
Publicado: (2014)